Compare Huntington Bancshares Incorporated (HBAN) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Smith & Nephew plc — how do they compare? Huntington Bancshares Incorporated trades at $18.13 (market cap $36.62B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Huntington Bancshares Incorporated is far larger — about 2.9× Smith & Nephew plc's market cap, and Huntington Bancshares Incorporated pays the higher dividend (3.43%). Which is the better fit depends on your goals.
| HBAN | SNN | |
|---|---|---|
Market Cap | $36.62B | $12.64B |
Sector | Financials | Health |
52-Week High | $19.27 | $38.70 |
52-Week Low | $15.02 | $28.73 |
Dividend Yield | 3.43% | 2.57% |
Enterprise Value | — | $15.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Huntington Bancshares (HBAN) trades at $18.17, down 0.44% on the day, with a bullish technical signal supported by moving averages. The stock shows a P/E of 13.9 and a net income margin of 25.13%, with Q2 2026 earnings expected at $0.39 per share. Recent news highlights the upcoming earnings report on July 23, 2026, and positive developments from the company's Texas expansion.
The outlook for HBAN is positive, driven by earnings growth potential and analyst consensus of $20.25 price target. Key risks include integration challenges from acquisitions and competitive pressures in regional banking markets. The stock presents a value opportunity with solid fundamentals, though investors should monitor expense management and loan growth trends.
SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.
Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
